Domenica Ceraulo

Publications by Year

Research Areas

Pancreatic and Hepatic Oncology Research, Neuroendocrine Tumor Research Advances, Cancer Genomics and Diagnostics, Renal cell carcinoma treatment, Colorectal Cancer Treatments and Studies

Most-Cited Works

• → Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial(2018)250 cited
• → (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial(2015)166 cited
• → Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial(2013)91 cited
• → A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma(2018)57 cited
• → Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma(2016)33 cited
• → Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial(2011)17 cited
• → Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma(2015)15 cited
• → Maintenance sunitinib (MS) or observation (O) in metastatic pancreatic adenocarcinoma (MPA): Clinical and translational results of a phase II randomized trial (NCT00967603).(2012)4 cited
• → Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (PAXG regimen) in unresectable or borderline resectable pancreatic adenocarcinoma(2016)3 cited
• → A randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in unresectable or borderline resectable pancreatic adenocarcinoma: the ghost regimen strikes back(2016)2 cited